What Democrats’ Drug-Price Probe Could Mean for Patients

House Democrats are preparing to scrutinize drug pricing as Congress returns to Washington, reviving a long-running debate over what patients pay and why.
Congress’s new health committee lineup could reshape oversight

Democratic control of Congress is set to alter the committees that steer Medicare, drug pricing and broader health policy, while adding lawmakers with medical and scientific backgrounds.
Medicare’s Remote Monitoring Delay Gives Opponents Time to Organize

Medicare has delayed a major remote patient monitoring overhaul until 2029, setting up a longer fight over how home-based tracking services are delivered, staffed, and paid for.
Why health costs are climbing as a campaign issue before Election Day

As open enrollment begins and voters head to the polls, Medicare changes, drug costs, and caregiving expenses are drawing fresh attention to the price of aging in America.
Medicare open enrollment starts with bigger drug-cost changes ahead

Medicare’s open enrollment season is under way, and several policy changes scheduled for 2027 could affect drug costs, plan choices and access to widely used diabetes and weight-loss medicines.
What the new $90 Medicare rebate means for older adults

A one-time $90 Medicare payment is arriving for some people in traditional Medicare Part B, but many beneficiaries are excluded — including those in Medicare Advantage.